{
    "2020-02-01": [
        [
            {
                "time": "",
                "original_text": "凯莱英：复工延迟影响收入端情况，利润端略超预期，毛利率有所提高【国盛医药张金洋团队】",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "复工延迟",
                        "收入端",
                        "利润端",
                        "毛利率"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "天津上市公司主动发挥各自优势驰援疫情一线",
                "features": {
                    "keywords": [
                        "天津",
                        "上市公司",
                        "驰援",
                        "疫情"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "凯莱英：公司及创始人捐赠善款和急需的医用设备合计300万元",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "捐赠",
                        "善款",
                        "医用设备"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "丽珠集团：丽珠微球平台国内第一，品种集中进入临床，研发进度加速【国盛医药张金洋团队】",
                "features": {
                    "keywords": [
                        "丽珠集团",
                        "微球平台",
                        "临床",
                        "研发进度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}